Abbott Laboratories Newsroom

Abbott Laboratories (ABT) Gets a Hold From Morgan Stanley

TipRanksJul 15 08:28 ET

Buy Rating Affirmed for Abbott Laboratories Amidst Strong Growth and Manageable Risks

TipRanksJul 11 04:22 ET

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $118 From $121

MT NewswiresJul 10 10:08 ET

Abbott Laboratories Analyst Ratings

BenzingaJul 2 10:57 ET

Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating

MT NewswiresJul 2 07:45 ET

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Springworks Therapeutics (SWTX)

TipRanksJul 2 07:05 ET

Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT)

TipRanksJul 2 07:02 ET

Abbott Laboratories Analyst Ratings

BenzingaJun 4 09:37 ET

Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115

MT NewswiresMay 30 09:17 ET

Abbott Laboratories Analyst Ratings

BenzingaMay 30 07:41 ET

Optimistic Buy Rating for Abbott Laboratories on Diverse Portfolio and Growth Prospects

TipRanksMay 30 04:27 ET

Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know

BenzingaMay 22 14:02 ET

Abbott Laboratories Analyst Ratings

BenzingaMay 22 13:18 ET

Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating

MT NewswiresMay 22 05:57 ET

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Immunocore Holdings (IMCR) and Madrigal Pharmaceuticals (MDGL)

TipRanksMay 20 07:31 ET

Analysts Conflicted on These Healthcare Names: Abbott Laboratories (ABT), PolyPid (PYPD) and GoodRx Holdings (GDRX)

TipRanksMay 20 06:01 ET

Buy Rating Affirmed for Abbott Laboratories Based on Strong EP Business and Strategic Growth Prospects

TipRanksMay 20 04:20 ET

RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)

TipRanksMay 7 08:10 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 22 08:37 ET

Abbott Laboratories Analyst Ratings

BenzingaApr 18 11:54 ET